1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 57874435, compound
Reaction equation
CCN(C(C)C)C(C)C.[C:10]1([N:16]2[CH:20]=[C:19]([C:21]([NH:23][CH2:24][C:25]([OH:27])=O)=[O:22])[N:18]=[CH:17]2)[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[F:50][C:51]1[CH:52]=[C:53]([CH:59]=[C:60]([C:62]([F:65])([F:64])[F:63])[CH:61]=1)[O:54][CH:55]1[CH2:58][NH:57][CH2:56]1>CN(C=O)C>[F:50][C:51]1[CH:52]=[C:53]([CH:59]=[C:60]([C:62]([F:64])([F:63])[F:65])[CH:61]=1)[O:54][CH:55]1[CH2:58][N:57]([C:25](=[O:27])[CH2:24][NH:23][C:21]([C:19]2[N:18]=[CH:17][N:16]([C:10]3[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH:20]=2)=[O:22])[CH2:56]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
DIPEA (143 mg, 1.1 mmol) was added to a stirred solution of [(1-phenyl-1H-imidazole-4-carbonyl)-amino]-acetic acid (prepared from Intermediate 68 by means of Step 3 of the General Scheme) (68 g, 0.27 mmol) in DMF (2 mL) followed by HOBt (39 mg, 0.29 mmol) and EDCI (56 mg, 0.29 mmol). After 2 minutes of stirring, 3-(3-fluoro-5-trifluoromethyl-phenoxy)-azetidine hydrochloride (prepared by the method used for the synthesis of Intermediate 71) (75 mg, 0.27 mmol) was added and it was stirred overnight at ambient temperature. Partitioning with cold water and ethyl acetate and concentration of the organic layer after drying over sodium sulfate afforded a residue which was purified by preparative HPLC to give 40 mg (31.4% Yield) of 1-phenyl-1H-imidazole-4-carboxylic acid {2-[3-(3-fluoro-5-trifluoromethyl-phenoxy)-azetidin-1-yl]-2-oxo-ethyl}-amide. LC/MS [M+H]+: 463, 99.18%. 1H NMR (300 MHz, DMSO-d6): δ 8.44 (d, 1H), 8.34 (d, 1H), 8.2 (t, 1H), 7.8 (d, 2H), 7.56 (t, 2H), 7.44 (m, 1H), 7.34 (d, 1H), 7.12 (m, 2H), 5.25 (m, 1H), 4.7 (m, 1H), 4.4 (m, 1H), 4.3 (m, 1H), 3.9 (m, 3H).
Workup
- additionwas added
- stirringit was stirred overnight at ambient temperature
- customPartitioning with cold water and ethyl acetate and concentration of the organic layer
- dry with materialafter drying over sodium sulfate
- customafforded a residue which
- customwas purified by preparative HPLC
Sources & evidence
- ORD record
- ord-6a768278bcb24b458239c9b29c1761d4
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08129376B2
Reaction notes
Loading…